Impact of U.S. Antidumping Duties on Amino Acid Exports
First written in FY2019. 2 of 4 entries say "Materialised", first in FY2019. Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024MitigatedAnnual report
「Tariff expense 227 —」
In the statement of cash flows, tariff expense of ¥227 million recorded in the previous fiscal year was not recorded in the current fiscal year. The reduction in current-period profit attributable to U.S. antidumping tariffs was smaller than in the previous period. - FY2024-Q3MitigatedAnnual report
「As the U.S. antidumping tariff expense recorded in the previous fiscal year was no longer incurred, ordinary profit was ¥485 million, up 38.6% from the same quarter of the previous year」
No U.S. antidumping tariff expense was recorded during the cumulative third quarter, and the absence of the tariff expense recorded in the same period of the previous year contributed to the increase in ordinary profit. The reduction in profit attributable to the tariff burden during the current period was smaller than in the previous period. - FY2023-Q3MaterialisedAnnual report
「In addition, the company was forced to record additional tariff expense related to its products subject to U.S. antidumping tariff measures. As a result, ordinary profit was ¥350 million, down 1.8% from the same quarter of the previous year.」
Additional tariff expense related to the U.S. antidumping tariff measures was recorded, bringing tariff expense for the cumulative third quarter to ¥222 million. The results show that the tariff burden reduced ordinary profit. - FY2019MaterialisedAnnual report
「In amino acid exports, the company was subject to a U.S. antidumping (AD) investigation into glycine made in Japan, including the company's products. On 24 April 2019, the company was notified by the U.S. Department of Commerce that the applicable AD tariff rate had been set at 53.66%. The company subsequently underwent a review by the U.S. International Trade Commission concerning whether to impose the AD tariff measures, and on 29 May 2019, the U.S. International Trade Commission issued its final determination to impose the AD tariff measures.」
Following the U.S. antidumping investigation into glycine made in Japan, the company disclosed the determination of a 53.66% tariff rate and the final determination to impose the tariff measures. The company stated that it was reviewing the impact on results from the current fiscal year onward.